Los Angeles Chronic Pain

Support and advocacy information for individuals dealing with chronic pain.

Building Bridges: How Patient Advocate Organizations and Researchers Can Work Together

For too long, clinical trials and research studies have been designed in ways that don’t always reflect the realities of the people most affected—the patients themselves. That’s starting to change, but it won’t happen fully unless we strengthen the partnership between patient advocate organizations and researchers.

I’ve seen both sides: the passion and rigor that researchers bring to the science, and the wisdom and lived experience that patients and advocates bring to the table. When those two come together with intention and respect, the science gets better—and so does the care.

Why Collaboration Matters

Clinical trials are the backbone of medical progress, but they can fall short if they don’t address what truly matters to patients. Think about it: a trial might test whether a new treatment reduces pain by two points on a numeric scale, but if it doesn’t improve sleep, mobility, or daily function, patients may not see it as meaningful.

Patient advocacy organizations bring deep networks, trust, and lived experience. They understand barriers to participation, cultural sensitivities, and the real-world priorities of the communities they serve. Researchers, on the other hand, bring scientific training, methods, and infrastructure. Together, they can:

  • Shape research questions that matter to patients.
  • Improve recruitment and retention by addressing real barriers.
  • Develop outcome measures that reflect lived priorities, not just lab numbers.
  • Ensure transparency and build trust in the research process.

What Collaboration Looks Like in Practice

Here are concrete ways patient advocate organizations and researchers can work side by side:

  1. Early Engagement – Bring advocates into the conversation during the planning phase, not just after the protocol is written. Ask: “What questions are most important to your community?”
  2. Shared Leadership – Include advocates in steering committees, data safety monitoring boards, and advisory panels. Give them a real vote, not just a seat.
  3. Tailored Communication – Researchers can lean on advocate organizations to craft recruitment materials and study updates in plain, accessible language.
  4. Equitable Compensation – Value patient advisors’ time and expertise just as you would any other professional contribution.
  5. Feedback Loops – Don’t just collect input—show how it shaped the study. That transparency builds trust and keeps people engaged.

Verified Examples of Existing Collaborations

PCORI’s Stakeholder Engagement and Pilot Projects

  • What they did: PCORI funded 50 pilot projects where patients, caregivers, and advocacy groups were integral partners. (pubmed.ncbi.nlm.nih.gov)
  • Lesson: Funders can require and support meaningful engagement; there are multiple models and methods, plus clear lessons learned.
  • Resource: Patient and Stakeholder Engagement in the PCORI Pilot Projects: Description and Lessons Learned.
    Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700002/

EUPATI CH (Switzerland)

  • What they did: A multi-stakeholder survey and interviews to understand experiences, barriers, and best practices for patient involvement in medicines R&D in Switzerland. (frontiersin.org)
  • Lesson: Local platforms can adapt global principles, assess where involvement is weak, and develop training and education to fill gaps.
  • Resource: The Role of EUPATI CH in Promoting Patient Involvement in Medicines R&D.
    Link: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2021.795659/full

EUPATI Guidance Document: Patient Involvement in Medicines R&D

  • What they did: Published multi-stakeholder guidance documents covering patient involvement across the medicines R&D lifecycle—industry, ethics committees, regulatory bodies, and HTA. (frontiersin.org)
  • Lesson: A formal framework and guidance help standardize expectations and give all stakeholders tools for meaningful engagement.
  • Resource: EUPATI Guidance for Patient Involvement in Medicines Research and Development (R&D); Guidance for Pharmaceutical Industry-Led Medicines R&D.
    Link: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2018.00270/full

University of Michigan: PainGuide and Stakeholder Panels (Must be a member to access)

  • What they did: The University of Michigan’s Chronic Pain & Fatigue Research Center created PainGuide in collaboration with people living with pain and convened stakeholder panels—including patient advocates—to shape research on pain care and opioid prescribing. (bacpac.painguide.med.umich.edu, ihpi.umich.edu)
  • Lesson: Even without a formal partnership with a national advocacy organization, these efforts highlight how academic centers can integrate patient advocates and lived experience into research and tool development.
  • What this means: When research centers intentionally involve patients and advocates, the outcomes—like PainGuide—are not only scientifically sound but also practical, accessible, and more likely to improve daily life for those of us living with chronic pain.

U.S. Pain Foundation: Partnering for Patient-Centered Research

  • What they did: The U.S. Pain Foundation has worked with researchers and federal agencies to bring the lived experience of people with chronic pain into national research priorities. For example, U.S. Pain has collaborated on projects aligned with the NIH’s HEAL Initiative and supported surveys such as #ThisIsPain: Unmasking Pain to identify patient needs and barriers. (uspainfoundation.org)
  • Lesson: National patient advocacy organizations can mobilize broad networks of people with lived experience, ensuring that large-scale research reflects the diversity of patient voices.
  • What this means: By building direct relationships with researchers and policymakers, advocacy groups like U.S. Pain help shift national agendas toward patient-centered care—making sure that real-world priorities such as function, quality of life, and access to non-opioid therapies are not overlooked.

What These Examples Teach Us

Pulling together lessons from those examples, here are more refined best practices, with evidence:

  • Training & Capacity Building Matter: It’s not enough to invite patient partners; people need support, education, and resources to participate effectively. (Seen in PCORI pilot projects, EUPATI CH, U.S. Pain Foundation programs)
  • Governance & Shared Decision-Making: Projects that embed patients/advocates in governance (steering committees, co-chairs, etc.) tend to make more sustainable, relevant changes.
  • Transparency & Feedback: Showing how patient input changed protocol, outcome measures, consent forms, etc., builds trust and improves engagement.
  • Tailored, Contextual Engagement: Engagement must consider cultural, national, regulatory, and disease-specific contexts. What works in Switzerland or Europe may need adaptation in the U.S. pain community.
  • Standardization + Flexibility: Guidance documents and frameworks help set expectations, but projects must adapt to specific circumstances.
  • Infrastructure (registries, data, platforms): Enables scaling, reduces burden, helps align patient-centered outcome measures across studies.

Call to Action

If you’re a researcher, here are concrete moves you can make now:

  • Reach out to patient advocacy groups before finalizing trial protocols.
  • Use existing frameworks (e.g. EUPATI’s guidance, PCORI’s engagement models) to structure involvement.
  • Allocate budget and time for training patient partners; build compensation into grants.
  • Use mixed forms of engagement (surveys, interviews, panels) to get broad input especially from under-represented groups.
  • Share lay summaries and report back how patient input shaped things.

If you’re part of a patient advocacy organization, here are steps to help strengthen collaboration:

  • Build or join networks that connect you with academic or industry researchers.
  • Develop internal capacity (training, resources) so your organization can engage effectively in trial design, consent processes, and ethics.
  • Collect stories and data about what patients prioritize and bring them into research agendas.
  • Advocate for funders and regulators to require meaningful patient engagement and make that visible.
  • Share your best practices with others (peer groups, online, publications) to spread what works.

Resources & Further Reading

Disclaimer: The views, positions, and recommendations expressed in this article are based on my personal experiences and independent research. They are solely my own and do not necessarily reflect the views, policies, or positions of the American Chronic Pain Association (ACPA).

Acknowledgment: This article was developed with the assistance of ChatGPT.

Discover more from Los Angeles Chronic Pain

Subscribe now to keep reading and get access to the full archive.

Continue reading